Question 1

What are the main differences between everolimus and mycophenolate mofetil?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection clinical trial (NCT00300274). Contact the study team or your healthcare provider for specific answers.

Question 2

How might the side effects of these medications differ?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection clinical trial (NCT00300274). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the chances of rejection with each treatment option?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection clinical trial (NCT00300274). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my recovery be monitored during this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection clinical trial (NCT00300274). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any specific lifestyle changes I should consider while on these medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection clinical trial (NCT00300274). Contact the study team or your healthcare provider for specific answers.

Question 6

What should I do if I experience side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection clinical trial (NCT00300274). Contact the study team or your healthcare provider for specific answers.

What this study is about